G+C Research Group

Miami, Florida 33134

0 studies enrolling now · 4 studies all time

What they study most

Covid19, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Opioid Use Disorder

Studies at this site

• A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension — Completed
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• SUBLOCADE Long-term Outcomes — Completed
• Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial — Status unconfirmed